Populus Health Technologies Partners with Patients, Physicians and Pharma Marketers to Create the First Comprehensive Report on Virtual Care in America

Why It Matters

The report delivers actionable insights for clinicians, payers and pharma, helping them refine digital‑health strategies as virtual care becomes a core component of American healthcare delivery.

Key Takeaways

• Over 1,250 respondents across patients, providers, pharma surveyed.
• Report offers first multi‑stakeholder view of U.S. virtual care.
• Findings to be featured in June 2026 PM360 editorial.
• DHC Group will release a Virtual Care Playbook for pharma marketers.
• Populus connects life‑science brands with patients at care moments.

Pulse Analysis

Virtual care has moved from a niche service to a mainstream channel for millions of Americans, accelerated by the COVID‑19 pandemic and sustained by ongoing reimbursement reforms. Industry analysts estimate the U.S. telehealth market will surpass $150 billion by 2028, driven by patient demand for convenience and provider incentives to expand digital offerings. As hospitals and health systems integrate video visits, remote monitoring, and patient portal messaging, the competitive landscape is reshaping, prompting stakeholders to seek data‑driven guidance on adoption trends and ROI.

The Populus Report fills a critical gap by aggregating perspectives from three key constituencies—patients, clinicians, and pharmaceutical marketers—through separate surveys of over 1,250 respondents. Questions probe usage frequency, condition suitability, technology integration challenges, regulatory concerns, and current investment levels. By triangulating these insights, the report delivers a holistic view of how virtual care is experienced, practiced, and marketed, offering benchmarks that were previously scattered across siloed studies. The upcoming June 2026 PM360 feature will distill these findings into actionable recommendations.

For pharma, the implications are profound. The data highlights new channels for patient engagement, targeted messaging at decision points, and improved medication adherence tracking—all enabled by virtual platforms. DHC Group’s accompanying Virtual Care Playbook translates the report’s insights into a tactical roadmap for marketers seeking to align product launches with digital touchpoints. Meanwhile, Populus’s precision‑attribution technology positions it as a bridge between life‑science brands and real‑time care moments, reinforcing its role as a strategic partner in the evolving telehealth ecosystem.